Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species

Indian Journal of Pathology and Microbiology

Volumn 54, Issue 1, 2011, Pages 112-116

  Misra, Richa ^a,b   Malik, Abida ^a   Singhal, Sanjay ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alamar Blue; Amphotericin B; Aspergillus; broth microdilution; itraconazole; voriconazole

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; ASPERGILLUS TERREUS; ASTHMA; BRONCHIECTASIS; BROTH DILUTION; CANCER RADIOTHERAPY; COLORIMETRY; CONTROLLED STUDY; FUNGUS CULTURE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LUNG LAVAGE; LUNG TUBERCULOSIS; MICROBIAL SENSITIVITY TEST; MICROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ORAL BIOPSY; PROSPECTIVE STUDY; SPUTUM;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; CLINICAL LABORATORY TECHNIQUES; CULTURE MEDIA; ENVIRONMENTAL MICROBIOLOGY; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MOUTH; MYCOLOGY; PYRIMIDINES; SPUTUM; TRIAZOLES;

EID: 79952956996     PISSN: 03774929     EISSN: 09745130     Source Type: Journal    
DOI: 10.4103/0377-4929.77352     Document Type: Article

References (20)

1. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: An autopsy study over a 15-year period (1989-2003). Haematologica 2006;91:986-9. (Pubitemid 44023159)
2. Zaoutis TE, Hayden K, Chu JH, Walsh TJ, Steinbach WJ. Epidemiology, Outcomes, and Costs of Invasive Aspergillosis in Immunocompromised Children in the United States. Pediatrics 2006;117:711-6.
3. Pfaller MA, Diekema DJ. Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004;42:4419-31 (Pubitemid 39362350)
4. Patterson TF. New agents for treatment of invasive aspergillosis. Clin Infect Dis 2002;35:367-9. (Pubitemid 34852564)
5. Perkhofer S, Lechner V, Lass-Florl C. In vitro Activity of Isavuconazole against Aspergillus species and Zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 2009;53:1645-7.
6. Denning DW, Venkateswarlu K, Oakley L, Anderson MJ, Manning NJ, Stevens DA, et al. Itraconazole resistance in Aspergillus Fumigatus. Antimicrob Agents chemother 1997;41:1364-8. (Pubitemid 27231443)
7. Espinel-Ingroff A, Kish CW, Kerkering TM, Fromtling RA, Bartizal K, Gagiani JN, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1992;30:3138-45.
8. Jahn B, Stuben A, Bhakdi S. Colorimetric susceptibility testing of Aspergillus fumigatus: Comparison of menadione-augmented 3-(4,5-dimethyl-2- thiazolyl)-2,5-2H-tetrazolium bromide and alamar blue tests. J Clin Microbiol 1996;34:2039-41. (Pubitemid 26239252)
9. Meletiadis J, Mouton JW, Meis J, Bouman B, Donnelly P, Verweij PE. Comparison of the Etest and for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2002;40:2876-85.
10. Espinel-Ingroff A, Bartlett M, Bowden R, Chin NX, Cooper Jr C, Fothergill A, et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997;35:139-43. (Pubitemid 26422642)
11. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. CLSI document M38-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2002.
12. Chandrasekar PH, Alangaden G, Manavathu E. Aspergillus: An increasing problem in tertiary care hospitals? Clin Infect Dis 2000;30:984-5. (Pubitemid 32250356)
13. Espinel-Ingroff A, Bartlett M, Chaturvedi V, Ghannoum M, Hazen KC, Pfaller MA, et al. Wild type MIC Distribution and Epidemiological Cutoff Values for Aspergillus fumigatus and Three Triazoles as Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Methods. Antimicrob Agents Chemother 2001;45:1828-35.
14. Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003;41:3623-6. (Pubitemid 36994692)
15. Guinea J, Peláez T, Recio S, Marta Torres-Narbona, Bouza E. In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species. Antimicrob Agents Chemother 2008;52:1396-400. (Pubitemid 351522004)
16. Verweij PE, Mensink M, Rijs AJ, Donnelly JP, Meis JF, Denning DW. In vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates J Clin Microbiol 1998;42:389-92. (Pubitemid 28442454)
17. Pfaller MA, Grant C, Morthaland V, Rhine-Chalberg J. Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J Clin Microbiol 1994;32:506-9. (Pubitemid 24033921)
18. Johnson EM, Szekely A, Warnock DW. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998;42:741-5. (Pubitemid 29008075)
19. Pfaller MA, Messer SA, Hollis RJ, Jones RN, The Sentry Participants Group. Antifungal activities of posaconazole, ravuconazole and voriconazole to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus species and other filamentous fungi: Report from SENTRY antimicrobial surveillance program.Antimicrob. Agents Chemother.2000;46:1032-7. (Pubitemid 34260347)
20. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 1999;37:3946-51.